{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:43:14Z","timestamp":1787503394577,"version":"build-2736575974"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.redox.2024.103478","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T12:07:09Z","timestamp":1734610029000},"page":"103478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Iron(ing) out parkinsonisms: The interplay of proteinopathy and ferroptosis in Parkinson's disease and tau-related parkinsonisms"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9625-5330","authenticated-orcid":false,"given":"Maria Jo\u00e3o","family":"da Costa Caiado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5400-5614","authenticated-orcid":false,"given":"Amalia M.","family":"Dolga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4168-1207","authenticated-orcid":false,"given":"Wilfred F.A.","family":"den Dunnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2024.103478_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101890","article-title":"Ferroptosis and its potential role in the physiopathology of Parkinson's Disease","volume":"196","author":"Mahoney-S\u00e1nchez","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.redox.2024.103478_bib2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.redox.2024.103478_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-022-00410-y","article-title":"Incidence of Parkinson disease in North America","volume":"8","author":"Willis","year":"2022","journal-title":"Npj Parkinsons Dis."},{"key":"10.1016\/j.redox.2024.103478_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/tcmj.tcmj_218_20","article-title":"Epidemiology of atypical parkinsonian syndromes","volume":"34","author":"Lo","year":"2021","journal-title":"Tzu Chi Med. J."},{"key":"10.1016\/j.redox.2024.103478_bib5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.redox.2024.103478_bib6","first-page":"61","article-title":"The differential diagnosis and treatment of atypical parkinsonism","volume":"113","author":"Levin","year":"2016","journal-title":"Dtsch Arztebl. Int."},{"key":"10.1016\/j.redox.2024.103478_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40478-020-00914-9","article-title":"Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series","volume":"8","author":"Geut","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.redox.2024.103478_bib8","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/brain\/awn065","article-title":"Clinical outcomes of progressive supranuclear palsy and multiple system atrophy","volume":"131","author":"O'Sullivan","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.redox.2024.103478_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder Society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.redox.2024.103478_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/WCO.0000000000000579","article-title":"Update in therapeutic strategies for Parkinson's disease","volume":"31","author":"Kulisevsky","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.redox.2024.103478_bib11","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.redox.2024.103478_bib12","doi-asserted-by":"crossref","first-page":"12727","DOI":"10.1074\/jbc.R117.781823","article-title":"Iron homeostasis: an anthropocentric perspective","volume":"292","author":"Coffey","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2024.103478_bib13","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1111\/febs.16059","article-title":"Signaling pathways and defense mechanisms of ferroptosis","volume":"289","author":"Liu","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.redox.2024.103478_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.745046","article-title":"The potential of ferroptosis-targeting therapies for Alzheimer's disease: from mechanism to transcriptomic analysis","volume":"13","author":"Majern\u00edkov\u00e1","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.redox.2024.103478_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103211","article-title":"Ferroptosis in health and disease","volume":"75","author":"Berndt","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2024.103478_bib16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.redox.2017.03.007","article-title":"BID links ferroptosis to mitochondrial cell death pathways","volume":"12","author":"Neitemeier","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2024.103478_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ceca.2017.05.007","article-title":"The role of Ca2+ in cell death caused by oxidative glutamate toxicity and ferroptosis","volume":"70","author":"Maher","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.redox.2024.103478_bib18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ejmech.2016.07.010","article-title":"Design of a novel thiophene inhibitor of 15-lipoxygenase-1 with both anti-inflammatory and neuroprotective properties","volume":"122","author":"Eleftheriadis","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.redox.2024.103478_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and transferrin regulate ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2024.103478_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bbrc.2020.07.032","article-title":"NEDD4L-mediated LTF protein degradation limits ferroptosis","volume":"531","author":"Wang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2024.103478_bib21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/pmic.201300342","article-title":"Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis","volume":"14","author":"Licker","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.redox.2024.103478_bib22","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2024.103478_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3390\/ijms23010537","article-title":"LC3\/FtMt colocalization patterns reveal the progression of FtMt accumulation in nigral neurons of patients with progressive supranuclear palsy","volume":"23","author":"Abu Bakar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2024.103478_bib24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.redox.2024.103478_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.redox.2024.103478_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.redox.2017.11.001","article-title":"\u03b1-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice","volume":"14","author":"Zhang","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2024.103478_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuroscience.2013.09.037","article-title":"Pro-inflammatory cytokine-mediated ferroportin down-regulation contributes to the nigral iron accumulation in lipopolysaccharide-induced Parkinsonian models","volume":"257","author":"Zhang","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.redox.2024.103478_bib28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/antiox10071021","article-title":"RT001 in progressive supranuclear palsy\u2014clinical and in-vitro observations","volume":"10","author":"Angelova","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2024.103478_bib29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/med.21712","article-title":"Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: finding ways for prevention","volume":"41","author":"Angelova","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.redox.2024.103478_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2024.103478_bib31","doi-asserted-by":"crossref","first-page":"25617","DOI":"10.1074\/jbc.M202285200","article-title":"AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis","volume":"277","author":"Wu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2024.103478_bib32","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.redox.2024.103478_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.redox.2024.103478_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13195-020-00714-2","article-title":"p47phox deficiency improves cognitive impairment and attenuates tau hyperphosphorylation in mouse models of AD","volume":"12","author":"Gong","year":"2020","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.redox.2024.103478_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102210","article-title":"Implication of type 4 NADPH oxidase (NOX4) in tauopathy","volume":"49","author":"Luengo","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2024.103478_bib36","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2024.103478_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/ars.2011.3960","article-title":"NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease","volume":"16","author":"Choi","year":"2012","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2024.103478_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/febs.15340","article-title":"Insoluble tau aggregates induce neuronal death through modification of membrane ion conductance, activation of voltage-gated calcium channels and NADPH oxidase","volume":"288","author":"Esteras","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.redox.2024.103478_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105754","article-title":"NADPH oxidase 2 activity in Parkinson's disease","volume":"170","author":"Keeney","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2024.103478_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-015-0189-z","article-title":"Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation","volume":"3","author":"Zawada","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.redox.2024.103478_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fendo.2013.00040","article-title":"NOX, NOX who is there? The contribution of NADPH oxidase one to beta cell dysfunction","volume":"4","author":"Taylor-Fishwick","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.redox.2024.103478_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814278","article-title":"A novel NOX inhibitor alleviates Parkinson's disease pathology in PFF-injected mice","volume":"24","author":"Ofori","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2024.103478_bib43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.freeradbiomed.2023.07.034","article-title":"Mitochondrial transplantation rescues neuronal cells from ferroptosis","volume":"208","author":"Chen","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2024.103478_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-023-06290-1","article-title":"Negative modulation of mitochondrial calcium uniporter complex protects neurons against ferroptosis","volume":"14","author":"Marmolejo-Garza","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2024.103478_bib45","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","article-title":"Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death","volume":"10","author":"Dixon","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.redox.2024.103478_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.redox.2024.103478_bib47","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","article-title":"Identification of ACSL4 as a biomarker and contributor of ferroptosis","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2024.103478_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","article-title":"Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1","volume":"81","author":"Yan","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2024.103478_bib49","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","article-title":"ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway","volume":"21","author":"Chu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.redox.2024.103478_bib50","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","article-title":"PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals","volume":"171","author":"Wenzel","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.redox.2024.103478_bib51","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1080\/15548627.2020.1739447","article-title":"Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death","volume":"17","author":"Li","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2024.103478_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00011-017-1022-x","article-title":"Effects of COX1-2\/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice","volume":"66","author":"Bitto","year":"2017","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.redox.2024.103478_bib53","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1369\/jhc.2008.951855","article-title":"Increased 5-lipoxygenase immunoreactivity in the Hippocampus of patients with Alzheimer's disease","volume":"56","author":"Ikonomovic","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.redox.2024.103478_bib54","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cbin.11505","article-title":"\u03b1-Lipoic acid alleviates ferroptosis in the MPP+-induced PC12 cells via activating the PI3K\/Akt\/Nrf2 pathway","volume":"45","author":"Liu","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.redox.2024.103478_bib55","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.molcel.2017.09.009","article-title":"NRF2 is a major target of ARF in p53-independent tumor suppression","volume":"68","author":"Chen","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2024.103478_bib56","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41419-019-2143-7","article-title":"Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis","volume":"10","author":"Gagliardi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2024.103478_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005800","article-title":"A glutathione-Nrf2-thioredoxin cross-talk ensures keratinocyte survival and efficient wound repair","volume":"12","author":"Telorack","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.redox.2024.103478_bib58","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2019.11.110","article-title":"ESCRT-III-dependent membrane repair blocks ferroptosis","volume":"522","author":"Dai","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2024.103478_bib59","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bbrc.2020.01.066","article-title":"AIFM2 blocks ferroptosis independent of ubiquinol metabolism","volume":"523","author":"Dai","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2024.103478_bib60","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1038\/s41418-020-0542-z","article-title":"Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation","volume":"27","author":"Angelova","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.redox.2024.103478_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116163","article-title":"Novel SK channel positive modulators prevent ferroptosis and excitotoxicity in neuronal cells","volume":"171","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.redox.2024.103478_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-2458-4","article-title":"SK channel-mediated metabolic escape to glycolysis inhibits ferroptosis and supports stress resistance in C. elegans","volume":"11","author":"Krabbendam","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2024.103478_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2021.102422","article-title":"PEG out through the pores with the help of ESCRTIII","volume":"97","author":"Marmolejo-Garza","year":"2021","journal-title":"Cell Calcium"},{"key":"10.1016\/j.redox.2024.103478_bib64","first-page":"1","article-title":"Implication of ferroptosis in aging","volume":"7","author":"Mazhar","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2024.103478_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101805","article-title":"Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms","volume":"190","author":"Sabogal-Gu\u00e1queta","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.redox.2024.103478_bib66","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fnmol.2018.00276","article-title":"Untangling tau and iron: exploring the interaction between iron and tau in neurodegeneration","volume":"11","author":"Rao","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.redox.2024.103478_bib67","first-page":"1531","article-title":"Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy","volume":"152","author":"P\u00e9rez","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.redox.2024.103478_bib68","doi-asserted-by":"crossref","first-page":"a009258","DOI":"10.1101\/cshperspect.a009258","article-title":"Parkinson's disease and parkinsonism: neuropathology","volume":"2","author":"Dickson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.redox.2024.103478_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.01399","article-title":"Alpha-synuclein physiology and pathology: a perspective on cellular structures and organelles","volume":"13","author":"Bernal-Conde","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.redox.2024.103478_bib70","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jnc.14810","article-title":"The physiological role of \u03b1-synuclein and its relationship to Parkinson's Disease","volume":"150","author":"Sulzer","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2024.103478_bib71","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JPD-150642","article-title":"The synaptic function of \u03b1-synuclein","volume":"5","author":"Burr\u00e9","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.redox.2024.103478_bib72","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/genes12081166","article-title":"Roles for \u03b1-synuclein in gene expression","volume":"12","author":"Somayaji","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.redox.2024.103478_bib73","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/brainsci13010150","article-title":"\u03b1-Synuclein and mechanisms of epigenetic regulation","volume":"13","author":"Surguchov","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.redox.2024.103478_bib74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/hmg\/ddy326","article-title":"Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein","volume":"28","author":"Pinho","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2024.103478_bib75","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.redox.2024.103478_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014530","article-title":"The physiological link between metabolic rate depression and tau phosphorylation in mammalian hibernation","volume":"6","author":"Stieler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2024.103478_bib77","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.conb.2021.03.003","article-title":"A current view on Tau protein phosphorylation in Alzheimer's disease","volume":"69","author":"Wegmann","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.redox.2024.103478_bib78","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1471-4159.1990.tb08814.x","article-title":"Decreased ferritin levels in brain in Parkinson's disease","volume":"55","author":"Dexter","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2024.103478_bib79","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.redox.2024.103478_bib80","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9961628","article-title":"Ferritinophagy-mediated ferroptosis involved in paraquat-induced neurotoxicity of dopaminergic neurons: implication for neurotoxicity in PD","volume":"2021","author":"Zuo","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2024.103478_bib81","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.freeradbiomed.2009.11.004","article-title":"Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease","volume":"48","author":"Song","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2024.103478_bib82","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1073\/pnas.0503804102","article-title":"The molecular basis of ferroportin-linked hemochromatosis","volume":"102","author":"De Domenico","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.redox.2024.103478_bib83","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s004010050468","article-title":"Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases","volume":"91","author":"Leveugle","year":"1996","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.redox.2024.103478_bib84","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neulet.2018.07.004","article-title":"Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease","volume":"684","author":"Si","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.redox.2024.103478_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106646","article-title":"Interactions of alpha-synuclein with membranes in Parkinson's disease: mechanisms and therapeutic strategies","volume":"201","author":"Li","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2024.103478_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110672","article-title":"Glucose metabolism impairment in Parkinson's disease","volume":"199","author":"Dai","year":"2023","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.redox.2024.103478_bib87","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-017-0225-5","article-title":"NADPH oxidases in Parkinson's disease: a systematic review","volume":"12","author":"Belarbi","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.redox.2024.103478_bib88","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/ars.2015.6343","article-title":"Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson's disease","volume":"24","author":"Deas","year":"2016","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.redox.2024.103478_bib89","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2246-12.2012","article-title":"NADPH oxidase 1 mediates \u03b1-synucleinopathy in Parkinson's disease","volume":"32","author":"Crist\u00f3v\u00e3o","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.redox.2024.103478_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2021.102362","article-title":"Mitochondrial dysfunction in neurodegenerative diseases: a focus on iPSC-derived neuronal models","volume":"94","author":"Trombetta-Lima","year":"2021","journal-title":"Cell Calcium"},{"key":"10.1016\/j.redox.2024.103478_bib91","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/cells8091072","article-title":"splitGFP technology reveals dose-dependent ER-mitochondria interface modulation by \u03b1-synuclein A53T and A30P mutants","volume":"8","author":"Cal\u00ec","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.redox.2024.103478_bib92","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2009.02.013","article-title":"PINK1-Associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death","volume":"33","author":"Gandhi","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2024.103478_bib93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(01)02514-9","article-title":"Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans","volume":"319","author":"Castellani","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.redox.2024.103478_bib94","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2016.10.490","article-title":"Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders","volume":"111","author":"Di Domenico","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2024.103478_bib95","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-6-8","article-title":"Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson's brain","volume":"6","author":"Bellinger","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.redox.2024.103478_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7769355","article-title":"Quercetin protects against MPP+\/MPTP-Induced dopaminergic neuron death in Parkinson's disease by inhibiting ferroptosis","volume":"2022","author":"Lin","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2024.103478_bib97","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1007\/s12035-021-02320-1","article-title":"Thioredoxin-1 rescues MPP+\/MPTP-Induced ferroptosis by increasing glutathione peroxidase 4","volume":"58","author":"Bai","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2024.103478_bib98","first-page":"414","article-title":"Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour","volume":"54","author":"Zecca","year":"2001","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.redox.2024.103478_bib99","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12640-017-9804-z","article-title":"Neuromelanin in Parkinson's disease: from Fenton reaction to calcium signaling","volume":"33","author":"Kn\u00f6rle","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.redox.2024.103478_bib100","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41467-020-15065-7","article-title":"Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson's disease","volume":"11","author":"Vallerga","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2024.103478_bib101","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.3390\/ijms23042378","article-title":"Ferritinophagy and \u03b1-synuclein: pharmacological targeting of autophagy to restore iron regulation in Parkinson's disease","volume":"23","author":"Boag","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2024.103478_bib102","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1471-4159.2007.05097.x","article-title":"Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism","volume":"104","author":"Cleren","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2024.103478_bib103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2008.09.069","article-title":"The coenzyme Q10 status of the brain regions of Parkinson's disease patients","volume":"447","author":"Hargreaves","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.redox.2024.103478_bib104","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ana.410420221","article-title":"Coenzyme Q10 levels correlate with the activities of complexes I and II\/III in mitochondria from parkinsonian and nonparkinsonian subjects","volume":"42","author":"Shults","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.redox.2024.103478_bib105","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.410320612","article-title":"Platelet mitochondrial function in Parkinson's disease. The royal kings and queens Parkinson disease research group","volume":"32","author":"Krige","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.redox.2024.103478_bib106","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2012.03.023","article-title":"Coenzyme Q10 deficiency in patients with Parkinson's disease","volume":"318","author":"Mischley","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.redox.2024.103478_bib107","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10072-016-2757-9","article-title":"The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials","volume":"38","author":"Zhu","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.redox.2024.103478_bib108","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1871527314666150821103306","article-title":"Coenzyme Q10 for patients with Parkinson's disease: a systematic review and meta-analysis","volume":"15","author":"Negida","year":"2016","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.redox.2024.103478_bib109","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2015.6549","article-title":"Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease","volume":"25","author":"Lastres-Becker","year":"2016","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2024.103478_bib110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","article-title":"Expression of Nrf2 in neurodegenerative diseases","volume":"66","author":"Ramsey","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.redox.2024.103478_bib111","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bbadis.2013.12.011","article-title":"Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases","volume":"1842","author":"Gan","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.redox.2024.103478_bib112","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1756-6606-5-35","article-title":"Mitochondrial dysfunction associated with increased oxidative stress and \u03b1-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue","volume":"5","author":"Imaizumi","year":"2012","journal-title":"Mol. Brain"},{"key":"10.1016\/j.redox.2024.103478_bib113","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.biocel.2013.02.012","article-title":"Role of \u03b1-synuclein aggregation and the nuclear factor E2-related factor 2\/heme oxygenase-1 pathway in iron-induced neurotoxicity","volume":"45","author":"He","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.redox.2024.103478_bib114","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaneurol.2018.1487","article-title":"Safety and tolerability of multiple ascending doses of PRX002\/RG7935, an anti\u2013\u03b1-synuclein monoclonal antibody, in patients with Parkinson disease: a randomized clinical trial","volume":"75","author":"Jankovic","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.redox.2024.103478_bib115","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2024.103478_bib116","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","article-title":"Trial of deferiprone in Parkinson's disease","volume":"387","author":"Devos","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2024.103478_bib117","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson's disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.redox.2024.103478_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101716","article-title":"Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective","volume":"184","author":"Derry","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.redox.2024.103478_bib119","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s004010100460","article-title":"A case of clinically and neuropathologically atypical corticobasal degeneration with widespread iron deposition","volume":"103","author":"Mizuno","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.redox.2024.103478_bib120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/WCO.0000000000001175","article-title":"Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum","volume":"36","author":"Whitwell","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.redox.2024.103478_bib121","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1471-4159.2002.t01-1-01061.x","article-title":"Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease","volume":"82","author":"Yamamoto","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2024.103478_bib122","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/alz.12282","article-title":"Regional brain iron associated with deterioration in Alzheimer's disease: a large cohort study and theoretical significance","volume":"17","author":"Ayton","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.redox.2024.103478_bib123","doi-asserted-by":"crossref","first-page":"II6","DOI":"10.1007\/BF03161076","article-title":"Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration","volume":"246","author":"Dickson","year":"1999","journal-title":"J. Neurol."},{"key":"10.1016\/j.redox.2024.103478_bib124","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/neup.12143","article-title":"Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration","volume":"34","author":"Yoshida","year":"2014","journal-title":"Neuropathology"},{"key":"10.1016\/j.redox.2024.103478_bib125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neurad.2022.09.002","article-title":"Susceptibility-weighted imaging in corticobasal degeneration: novel insights from a new case","volume":"49","author":"Rodr\u00edguez-Castro","year":"2022","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.redox.2024.103478_bib126","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-016-0292-9","article-title":"Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy","volume":"4","author":"Piras","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.redox.2024.103478_bib127","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3390\/cells9092135","article-title":"Mitochondrial calcium deregulation in the mechanism of beta-amyloid and tau pathology","volume":"9","author":"Esteras","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.redox.2024.103478_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2019.102150","article-title":"Tau inhibits mitochondrial calcium efflux and makes neurons vulnerable to calcium-induced cell death","volume":"86","author":"Britti","year":"2020","journal-title":"Cell Calcium"},{"key":"10.1016\/j.redox.2024.103478_bib129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jnen\/59.5.393","article-title":"Lipoperoxidation is selectively involved in progressive supranuclear palsy","volume":"59","author":"Odetti","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.redox.2024.103478_bib130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1468-1331.2006.01139.x","article-title":"Aging and oxidative stress in progressive supranuclear palsy","volume":"13","author":"Aoyama","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.redox.2024.103478_bib131","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3233\/JAD-2011-111190","article-title":"Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice","volume":"28","author":"Elipenahli","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.redox.2024.103478_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.910289","article-title":"Investigation of coenzyme Q10 status, serum amyloid-\u03b2, and tau protein in patients with dementia","volume":"14","author":"Chang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.redox.2024.103478_bib133","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3390\/antiox12081564","article-title":"Aging, NRF2, and TAU: perfect match for neurodegeneration?","volume":"12","author":"Brackhan","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2024.103478_bib134","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1038\/ncomms4496","article-title":"Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52","volume":"5","author":"Jo","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2024.103478_bib135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2017.12.001","article-title":"Nrf2 mediates the expression of BAG3 and autophagy cargo adaptor proteins and tau clearance in an age dependent manner","volume":"63","author":"Tang","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.redox.2024.103478_bib136","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s11357-023-00760-2","article-title":"Effect of Nrf2 loss on senescence and cognition of tau-based P301S mice","volume":"45","author":"Riordan","year":"2023","journal-title":"GeroScience"},{"key":"10.1016\/j.redox.2024.103478_bib137","doi-asserted-by":"crossref","first-page":"371","DOI":"10.15252\/emmm.201606664","article-title":"PERK activation mitigates tau pathology in vitro and in vivo","volume":"9","author":"Bruch","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.redox.2024.103478_bib138","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0006-8993(95)00535-X","article-title":"Evidence for oxidative stress in Pick disease and corticobasal degeneration","volume":"696","author":"Castellani","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.redox.2024.103478_bib139","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/s41380-019-0375-7","article-title":"Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology","volume":"25","author":"Ayton","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.redox.2024.103478_bib140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.2613","article-title":"Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export","volume":"18","author":"Lei","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2024.103478_bib141","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1038\/s41467-022-30585-0","article-title":"Fluent molecular mixing of Tau isoforms in Alzheimer's disease neurofibrillary tangles","volume":"13","author":"Dregni","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2024.103478_bib142","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","article-title":"Distinct tau prion strains propagate in cells and mice and define different tauopathies","volume":"82","author":"Sanders","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.redox.2024.103478_bib143","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","article-title":"Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo","volume":"92","author":"Kaufman","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.redox.2024.103478_bib144","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1073\/pnas.1301175110","article-title":"Brain homogenates from human tauopathies induce tau inclusions in mouse brain","volume":"110","author":"Clavaguera","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2024.103478_bib145","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.trci.2018.10.007","article-title":"A randomized, single ascending dose study of intravenous BIIB092 in healthy participants","volume":"4","author":"Qureshi","year":"2018","journal-title":"Alzheimer's Dementia : Translat. Res. Clin. Interv."},{"key":"10.1016\/j.redox.2024.103478_bib146","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1474-4422(19)30139-5","article-title":"Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial","volume":"18","author":"Boxer","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.redox.2024.103478_bib147","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1212\/NXI.0000000000000266","article-title":"CoQ10 in progressive supranuclear palsy: a randomized, placebo-controlled, double-blind trial","volume":"3","author":"Apetauerova","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.redox.2024.103478_bib148","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1007\/s12035-022-02731-8","article-title":"Ferroptosis promotes microtubule-associated protein tau aggregation via GSK-3\u03b2 activation and proteasome inhibition","volume":"59","author":"Wang","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2024.103478_bib149","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy","volume":"29","author":"Tolosa","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.redox.2024.103478_bib150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.25815","article-title":"Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial","volume":"29","author":"H\u00f6glinger","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.redox.2024.103478_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.947191","article-title":"The relationship of alpha-synuclein to mitochondrial dynamics and quality control","volume":"15","author":"Thorne","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.redox.2024.103478_bib152","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.febslet.2015.10.021","article-title":"Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease","volume":"589","author":"Haddad","year":"2015","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.redox.2024.103478_bib153","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1093\/hmg\/ddv340","article-title":"F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2024.103478_bib154","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/NEN.0b013e318293c586","article-title":"FBXO7 immunoreactivity in \u03b1-synuclein-containing inclusions in Parkinson disease and multiple system atrophy","volume":"72","author":"Zhao","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.redox.2024.103478_bib155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1471-4159.2009.06316.x","article-title":"Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport","volume":"111","author":"Stoothoff","year":"2009","journal-title":"J. Neurochem."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231724004567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231724004567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T03:28:01Z","timestamp":1736738881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231724004567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":155,"alternative-id":["S2213231724004567"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2024.103478","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron(ing) out parkinsonisms: The interplay of proteinopathy and ferroptosis in Parkinson's disease and tau-related parkinsonisms","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2024.103478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103478"}}